BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mann DL, Lee RJ, Coats AJ, Neagoe G, Dragomir D, Pusineri E, Piredda M, Bettari L, Kirwan B, Dowling R, Volterrani M, Solomon SD, Sabbah HN, Hinson A, Anker SD. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure: One-year follow-up results from AUGMENT-HF. Eur J Heart Fail 2016;18:314-25. [DOI: 10.1002/ejhf.449] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
Number Citing Articles
1 Iop L, Palmosi T, Dal Sasso E, Gerosa G. Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery. J Thorac Dis 2018;10:S2390-411. [PMID: 30123578 DOI: 10.21037/jtd.2018.04.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
2 O’dwyer J, Murphy R, Dolan EB, Kovarova L, Pravda M, Velebny V, Heise A, Duffy GP, Cryan SA. Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium. Drug Deliv and Transl Res 2020;10:440-54. [DOI: 10.1007/s13346-019-00684-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
3 Janaswamy P, Walters TE, Nazer B, Lee RJ. Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction. Curr Treat Options Cardiovasc Med 2016;18:57. [PMID: 27488313 DOI: 10.1007/s11936-016-0479-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
4 Sack KL, Aliotta E, Choy JS, Ennis DB, Davies NH, Franz T, Kassab GS, Guccione JM. Effect of intra-myocardial Algisyl-LVR™ injectates on fibre structure in porcine heart failure. J Mech Behav Biomed Mater 2018;87:172-9. [PMID: 30071487 DOI: 10.1016/j.jmbbm.2018.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Garcia JR, Campbell PF, Kumar G, Langberg JJ, Cesar L, Deppen JN, Shin EY, Bhatia NK, Wang L, Xu K, Schneider F, Robinson B, García AJ, Levit RD. Minimally Invasive Delivery of Hydrogel-Encapsulated Amiodarone to the Epicardium Reduces Atrial Fibrillation. Circ Arrhythm Electrophysiol 2018;11:e006408. [PMID: 29748197 DOI: 10.1161/CIRCEP.118.006408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
6 Rao SV, Zeymer U, Douglas PS, Al-Khalidi H, White JA, Liu J, Levy H, Guetta V, Gibson CM, Tanguay JF, Vermeersch P, Roncalli J, Kasprzak JD, Henry TD, Frey N, Kracoff O, Traverse JH, Chew DP, Lopez-Sendon J, Heyrman R, Krucoff MW. Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. J Am Coll Cardiol 2016;68:715-23. [PMID: 27515331 DOI: 10.1016/j.jacc.2016.05.053] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
7 Zhu Y, Matsumura Y, Wagner WR. Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences. Biomaterials 2017;129:37-53. [PMID: 28324864 DOI: 10.1016/j.biomaterials.2017.02.032] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
8 Sack KL, Aliotta E, Choy JS, Ennis DB, Davies NH, Franz T, Kassab GS, Guccione JM. Intra-myocardial alginate hydrogel injection acts as a left ventricular mid-wall constraint in swine. Acta Biomater 2020;111:170-80. [PMID: 32428678 DOI: 10.1016/j.actbio.2020.04.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Li H, Bao M, Nie Y. Extracellular matrix-based biomaterials for cardiac regeneration and repair. Heart Fail Rev 2021;26:1231-48. [PMID: 32306220 DOI: 10.1007/s10741-020-09953-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Vasanthan V, Fatehi Hassanabad A, Pattar S, Niklewski P, Wagner K, Fedak PWM. Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials. Front Bioeng Biotechnol 2020;8:291. [PMID: 32363184 DOI: 10.3389/fbioe.2020.00291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Nguyen PK, Neofytou E, Rhee JW, Wu JC. Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. JAMA Cardiol 2016;1:953-62. [PMID: 27579998 DOI: 10.1001/jamacardio.2016.2750] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 15.5] [Reference Citation Analysis]
12 Kassab GS, Choy JS, Guccione JM. Reply to Letter to Editor by S Tong, L Zhang, J Joseph, and X Jiang "A potential and novel therapeutic approach to ischemic heart failure: Algisyl-LVR". Int J Cardiol 2019;279:133. [PMID: 30704644 DOI: 10.1016/j.ijcard.2018.09.111] [Reference Citation Analysis]
13 Gallagher LB, Dolan EB, O'sullivan J, Levey R, Cavanagh BL, Kovarova L, Pravda M, Velebny V, Farrell T, O'brien FJ, Duffy GP. Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions. Acta Biomaterialia 2020;107:78-90. [DOI: 10.1016/j.actbio.2020.02.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
14 Emami A, Ebner N, von Haehling S. Publishing in a heart failure journal-where lies the scientific interest? ESC Heart Fail 2017;4:389-401. [PMID: 29131547 DOI: 10.1002/ehf2.12233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Perveen S, Rossin D, Vitale E, Rosso R, Vanni R, Cristallini C, Rastaldo R, Giachino C. Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions. Int J Mol Sci 2021;22:13054. [PMID: 34884856 DOI: 10.3390/ijms222313054] [Reference Citation Analysis]
16 Di Franco S, Amarelli C, Montalto A, Loforte A, Musumeci F. Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart". J Thorac Dis 2018;10:S2346-62. [PMID: 30123575 DOI: 10.21037/jtd.2018.01.85] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Schotman MJG, Dankers PYW. Factors Influencing Retention of Injected Biomaterials to Treat Myocardial Infarction. Adv Materials Inter. [DOI: 10.1002/admi.202100942] [Reference Citation Analysis]
18 Lv K, Li Q, Zhang L, Wang Y, Zhong Z, Zhao J, Lin X, Wang J, Zhu K, Xiao C, Ke C, Zhong S, Wu X, Chen J, Yu H, Zhu W, Li X, Wang B, Tang R, Wang J, Huang J, Hu X. Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction. Theranostics 2019;9:7403-16. [PMID: 31695776 DOI: 10.7150/thno.32637] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
19 McCune C, McKavanagh P, Menown IB. A Review of the Key Clinical Trials of 2015: Results and Implications. Cardiol Ther 2016;5:109-32. [PMID: 27277596 DOI: 10.1007/s40119-016-0063-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Garcia JR, Campbell PF, Kumar G, Langberg JJ, Cesar L, Wang L, García AJ, Levit RD. A Minimally Invasive, Translational Method to Deliver Hydrogels to the Heart Through the Pericardial Space. JACC Basic Transl Sci 2017;2:601-9. [PMID: 30062173 DOI: 10.1016/j.jacbts.2017.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
21 Wen Y, Li XY, Li ZY, Wang ML, Chen PP, Liu Y, Zhang XZ, Jiang XJ. Intra-myocardial Delivery of a Novel Thermosensitive Hydrogel Inhibits Post-infarct Heart Failure After Degradation in Rat. J Cardiovasc Transl Res 2020;13:677-85. [PMID: 32020504 DOI: 10.1007/s12265-019-09941-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cattelan G, Guerrero Gerbolés A, Foresti R, Pramstaller PP, Rossini A, Miragoli M, Caffarra Malvezzi C. Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration. Front Bioeng Biotechnol 2020;8:414. [PMID: 32457887 DOI: 10.3389/fbioe.2020.00414] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
23 Ahmad Raus R, Wan Nawawi WMF, Nasaruddin RR. Alginate and alginate composites for biomedical applications. Asian J Pharm Sci 2021;16:280-306. [PMID: 34276819 DOI: 10.1016/j.ajps.2020.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Chen R, Zhu C, Xu L, Gu Y, Ren S, Bai H, Zhou Q, Liu X, Lu S, Bi X, Li W, Jia X, Chen Z. An injectable peptide hydrogel with excellent self-healing ability to continuously release salvianolic acid B for myocardial infarction. Biomaterials 2021;274:120855. [PMID: 33975276 DOI: 10.1016/j.biomaterials.2021.120855] [Reference Citation Analysis]
25 Onaciu A, Munteanu RA, Moldovan AI, Moldovan CS, Berindan-Neagoe I. Hydrogels Based Drug Delivery Synthesis, Characterization and Administration. Pharmaceutics 2019;11:E432. [PMID: 31450869 DOI: 10.3390/pharmaceutics11090432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
26 Rodell CB, Zhang ZL, Dusaj NN, Oquendo Y, Lee ME, Bouma W, Gorman JH 3rd, Burdick JA, Gorman RC. Injectable Shear-Thinning Hydrogels Prevent Ischemic Mitral Regurgitation and Normalize Ventricular Flow Dynamics. Semin Thorac Cardiovasc Surg 2020;32:445-53. [PMID: 31682905 DOI: 10.1053/j.semtcvs.2019.10.015] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Contessotto P, Orbanić D, Da Costa M, Jin C, Owens P, Chantepie S, Chinello C, Newell J, Magni F, Papy-Garcia D, Karlsson NG, Kilcoyne M, Dockery P, Rodríguez-Cabello JC, Pandit A. Elastin-like recombinamers-based hydrogel modulates post-ischemic remodeling in a non-transmural myocardial infarction in sheep. Sci Transl Med 2021;13:eaaz5380. [PMID: 33597263 DOI: 10.1126/scitranslmed.aaz5380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
28 Curley CJ, Dolan EB, Otten M, Hinderer S, Duffy GP, Murphy BP. An injectable alginate/extra cellular matrix (ECM) hydrogel towards acellular treatment of heart failure. Drug Deliv and Transl Res 2019;9:1-13. [DOI: 10.1007/s13346-018-00601-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
29 Spinale FG. Improving Delivery of a Biomaterial Payload in Myocardial Infarction. Circ Cardiovasc Interv 2016;9:e004489. [PMID: 27729420 DOI: 10.1161/CIRCINTERVENTIONS.116.004489] [Reference Citation Analysis]
30 Cui Z, Yang B, Li R. Application of Biomaterials in Cardiac Repair and Regeneration. Engineering 2016;2:141-8. [DOI: 10.1016/j.eng.2016.01.028] [Cited by in Crossref: 45] [Article Influence: 7.5] [Reference Citation Analysis]
31 Majid QA, Fricker ATR, Gregory DA, Davidenko N, Hernandez Cruz O, Jabbour RJ, Owen TJ, Basnett P, Lukasiewicz B, Stevens M, Best S, Cameron R, Sinha S, Harding SE, Roy I. Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution. Front Cardiovasc Med 2020;7:554597. [PMID: 33195451 DOI: 10.3389/fcvm.2020.554597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Menasché P. Cell therapy trials for heart regeneration - lessons learned and future directions. Nat Rev Cardiol 2018;15:659-71. [PMID: 29743563 DOI: 10.1038/s41569-018-0013-0] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 40.0] [Reference Citation Analysis]
33 MacArthur JW, Steele AN, Goldstone AB, Cohen JE, Hiesinger W, Woo YJ. Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy. Curr Treat Options Cardiovasc Med 2017;19:30. [PMID: 28337717 DOI: 10.1007/s11936-017-0530-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Mewhort HEM, Svystonyuk DA, Turnbull JD, Teng G, Belke DD, Guzzardi DG, Park DS, Kang S, Hollenberg MD, Fedak PWM. Bioactive Extracellular Matrix Scaffold Promotes Adaptive Cardiac Remodeling and Repair. JACC Basic Transl Sci 2017;2:450-64. [PMID: 30062163 DOI: 10.1016/j.jacbts.2017.05.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
35 Pomeroy JE, Helfer A, Bursac N. Biomaterializing the promise of cardiac tissue engineering. Biotechnol Adv 2020;42:107353. [PMID: 30794878 DOI: 10.1016/j.biotechadv.2019.02.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
36 Bannerman D, Pascual-Gil S, Radisic M. An optimal gel patch for the injured heart. Nat Biomed Eng 2019;3:592-3. [PMID: 31391591 DOI: 10.1038/s41551-019-0440-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Contessotto P, Pandit A. Therapies to prevent post-infarction remodelling: From repair to regeneration. Biomaterials 2021;275:120906. [PMID: 34139506 DOI: 10.1016/j.biomaterials.2021.120906] [Reference Citation Analysis]
38 Levit RD. Nature and Nurture: It Matters for Stem Cells, Too. JACC Basic Transl Sci 2016;1:373-5. [PMID: 30167525 DOI: 10.1016/j.jacbts.2016.07.004] [Reference Citation Analysis]
39 Liu Z, Mikrani R, Zubair HM, Taleb A, Naveed M, Baig MMFA, Zhang Q, Li C, Habib M, Cui X, Sembatya KR, Lei H, Zhou X. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations. Eur J Pharmacol 2020;876:173049. [PMID: 32142771 DOI: 10.1016/j.ejphar.2020.173049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
40 Curley CJ, Dolan EB, Cavanagh B, O'Sullivan J, Duffy GP, Murphy BP. An in vitro investigation to assess procedure parameters for injecting therapeutic hydrogels into the myocardium. J Biomed Mater Res B Appl Biomater 2017;105:2618-29. [PMID: 27764526 DOI: 10.1002/jbm.b.33802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
41 Pezzana C, Agnely F, Bochot A, Siepmann J, Menasché P. Extracellular Vesicles and Biomaterial Design: New Therapies for Cardiac Repair. Trends Mol Med 2021;27:231-47. [PMID: 33218944 DOI: 10.1016/j.molmed.2020.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Saludas L, Pascual-gil S, Prósper F, Garbayo E, Blanco-prieto M. Hydrogel based approaches for cardiac tissue engineering. International Journal of Pharmaceutics 2017;523:454-75. [DOI: 10.1016/j.ijpharm.2016.10.061] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 12.6] [Reference Citation Analysis]
43 Ferrari MR, Di Maria MV, Jacot JG. Review on Mechanical Support and Cell-Based Therapies for the Prevention and Recovery of the Failed Fontan-Kreutzer Circulation. Front Pediatr 2020;8:627660. [PMID: 33575233 DOI: 10.3389/fped.2020.627660] [Reference Citation Analysis]
44 Chen MH, Chung JJ, Mealy JE, Zaman S, Li EC, Arisi MF, Atluri P, Burdick JA. Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery. Macromol Biosci 2019;19:e1800248. [PMID: 30259658 DOI: 10.1002/mabi.201800248] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
45 Liu W, Zhao L, Wang C, Zhou J. Conductive nanomaterials for cardiac tissues engineering. Engineered Regeneration 2020;1:88-94. [DOI: 10.1016/j.engreg.2020.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Hernandez MJ, Christman KL. Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease. JACC Basic Transl Sci 2017;2:212-26. [PMID: 29057375 DOI: 10.1016/j.jacbts.2016.11.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
47 Portillo Esquivel LE, Zhang B. Application of Cell, Tissue, and Biomaterial Delivery in Cardiac Regenerative Therapy. ACS Biomater Sci Eng 2021;7:1000-21. [PMID: 33591735 DOI: 10.1021/acsbiomaterials.0c01805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Metra M, Teerlink JR. Heart failure. The Lancet 2017;390:1981-95. [DOI: 10.1016/s0140-6736(17)31071-1] [Cited by in Crossref: 242] [Cited by in F6Publishing: 98] [Article Influence: 48.4] [Reference Citation Analysis]
49 Dabiri Y, Sack KL, Shaul S, Acevedo-Bolton G, Choy JS, Kassab GS, Guccione JM. Intramyocardial Injections to De-Stiffen the Heart: A Subject-Specific in Silico Approach. Mol Cell Biomech 2019;16:185-97. [PMID: 32063808 DOI: 10.32604/mcb.2019.07364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Tenreiro MF, Louro AF, Alves PM, Serra M. Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering. NPJ Regen Med 2021;6:30. [PMID: 34075050 DOI: 10.1038/s41536-021-00140-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Govea A, Lee RJ. Pericardial Delivery of Biological Agents: The Next Frontier? JACC Basic Transl Sci 2017;2:610-2. [PMID: 30062174 DOI: 10.1016/j.jacbts.2017.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Choy JS, Leng S, Acevedo-Bolton G, Shaul S, Fu L, Guo X, Zhong L, Guccione JM, Kassab GS. Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine. Int J Cardiol 2018;255:129-35. [PMID: 29425550 DOI: 10.1016/j.ijcard.2017.09.179] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
53 Hendriks T, Schurer RAJ, Al Ali L, van den Heuvel AFM, van der Harst P. Left ventricular restoration devices post myocardial infarction. Heart Fail Rev 2018;23:871-83. [PMID: 29770903 DOI: 10.1007/s10741-018-9711-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Ramaraju H, Solorio LD, Bocks ML, Hollister SJ. Degradation properties of a biodegradable shape memory elastomer, poly(glycerol dodecanoate), for soft tissue repair. PLoS One 2020;15:e0229112. [PMID: 32084184 DOI: 10.1371/journal.pone.0229112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
55 Wu R, Hu X, Wang J. Concise Review: Optimized Strategies for Stem Cell-Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation. Stem Cells. 2018;36:482-500. [PMID: 29330880 DOI: 10.1002/stem.2778] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
56 Anker MS, Hadzibegovic S, Lena A, Haverkamp W. The difference in referencing in Web of Science, Scopus, and Google Scholar. ESC Heart Fail 2019;6:1291-312. [PMID: 31886636 DOI: 10.1002/ehf2.12583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
57 Fujita B, Zimmermann WH. Myocardial Tissue Engineering for Regenerative Applications. Curr Cardiol Rep 2017;19:78. [PMID: 28752277 DOI: 10.1007/s11886-017-0892-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
58 Ahmad U, Lilly SM. Interventional Heart Failure and Hemodynamic Monitoring. Heart Fail Clin 2018;14:625-34. [PMID: 30266370 DOI: 10.1016/j.hfc.2018.06.007] [Reference Citation Analysis]
59 Totten JD, Alhadrami HA, Jiffri EH, McMullen CJ, Seib FP, Carswell HVO. Towards clinical translation of 'second-generation' regenerative stroke therapies: hydrogels as game changers? Trends Biotechnol 2021:S0167-7799(21)00255-9. [PMID: 34815101 DOI: 10.1016/j.tibtech.2021.10.009] [Reference Citation Analysis]
60 Midgett D, Thorn S, Ahn S, Uman S, Avendano R, Melvinsdottir I, Lysyy T, Kim S, Duncan J, Humphrey J, Papademetris X, Burdick J, Sinusas A. CineCT platform for in vivo and ex vivo measurement of 3D high resolution Lagrangian strains in the left ventricle following myocardial infarction and intramyocardial delivery of theranostic hydrogel. Journal of Molecular and Cellular Cardiology 2022. [DOI: 10.1016/j.yjmcc.2022.02.004] [Reference Citation Analysis]
61 McNally EM, Mestroni L. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res 2017;121:731-48. [PMID: 28912180 DOI: 10.1161/CIRCRESAHA.116.309396] [Cited by in Crossref: 249] [Cited by in F6Publishing: 154] [Article Influence: 49.8] [Reference Citation Analysis]
62 Tong S, Zhang L, Joseph J, Jiang X. A potential and novel therapeutic approach to ischemic heart failure: Algisyl-LVR. Int J Cardiol 2018;271:209. [PMID: 30100223 DOI: 10.1016/j.ijcard.2018.05.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Nadlacki B, Suuronen EJ. Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction. Expert Opinion on Biological Therapy 2016;16:1501-16. [DOI: 10.1080/14712598.2016.1235149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 Moroni F, Castelvecchio S, Menicanti L. Reshaping the failing heart: One step forward in elucidating the role of biomaterials in preventing cardiac remodeling. Int J Cardiol 2018;255:152-3. [PMID: 29425554 DOI: 10.1016/j.ijcard.2017.12.072] [Reference Citation Analysis]
65 Gokce C, Gurcan C, Delogu LG, Yilmazer A. 2D Materials for Cardiac Tissue Repair and Regeneration. Front Cardiovasc Med 2022;9:802551. [DOI: 10.3389/fcvm.2022.802551] [Reference Citation Analysis]
66 Liao X, Yang X, Deng H, Hao Y, Mao L, Zhang R, Liao W, Yuan M. Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases. Front Bioeng Biotechnol 2020;8:251. [PMID: 32296694 DOI: 10.3389/fbioe.2020.00251] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
67 Dolan EB, Hofmann B, de Vaal MH, Bellavia G, Straino S, Kovarova L, Pravda M, Velebny V, Daro D, Braun N, Monahan DS, Levey RE, O'neill H, Hinderer S, Greensmith R, Monaghan MG, Schenke-layland K, Dockery P, Murphy BP, Kelly HM, Wildhirt S, Duffy GP. A bioresorbable biomaterial carrier and passive stabilization device to improve heart function post-myocardial infarction. Materials Science and Engineering: C 2019;103:109751. [DOI: 10.1016/j.msec.2019.109751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
68 Anker MS, von Haehling S, Papp Z, Anker SD. ESC Heart Failure receives its first impact factor. Eur J Heart Fail 2019;21:1490-e8. [PMID: 31883221 DOI: 10.1002/ejhf.1665] [Reference Citation Analysis]
69 Streeter BW, Davis ME. Therapeutic Cardiac Patches for Repairing the Myocardium. In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 5. Cham: Springer International Publishing; 2019. pp. 1-24. [DOI: 10.1007/5584_2018_309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
70 Genç H, Hazur J, Karakaya E, Dietel B, Bider F, Groll J, Alexiou C, Boccaccini AR, Detsch R, Cicha I. Differential Responses to Bioink-Induced Oxidative Stress in Endothelial Cells and Fibroblasts. Int J Mol Sci 2021;22:2358. [PMID: 33652991 DOI: 10.3390/ijms22052358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Traverse JH, Henry TD, Dib N, Patel AN, Pepine C, Schaer GL, DeQuach JA, Kinsey AM, Chamberlin P, Christman KL. First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients. JACC Basic Transl Sci 2019;4:659-69. [PMID: 31709316 DOI: 10.1016/j.jacbts.2019.07.012] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 21.3] [Reference Citation Analysis]
72 Dolan EB, Kovarova L, O'Neill H, Pravda M, Sulakova R, Scigalkova I, Velebny V, Daro D, Braun N, Cooney GM, Bellavia G, Straino S, Cavanagh BL, Flanagan A, Kelly HM, Duffy GP, Murphy BP. Advanced Material Catheter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels. J Biomater Appl 2018;33:681-92. [PMID: 30354912 DOI: 10.1177/0885328218805878] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
73 Matsumura Y, Zhu Y, Jiang H, D'amore A, Luketich SK, Charwat V, Yoshizumi T, Sato H, Yang B, Uchibori T, Healy KE, Wagner WR. Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction. Biomaterials 2019;217:119289. [DOI: 10.1016/j.biomaterials.2019.119289] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
74 Ramaraju H, Ul-Haque A, Verga AS, Bocks ML, Hollister SJ. Modulating nonlinear elastic behavior of biodegradable shape memory elastomer and small intestinal submucosa(SIS) composites for soft tissue repair. J Mech Behav Biomed Mater 2020;110:103965. [PMID: 32957256 DOI: 10.1016/j.jmbbm.2020.103965] [Reference Citation Analysis]
75 Taylor DA, Parikh RB, Sampaio LC. Bioengineering Hearts: Simple yet Complex. Curr Stem Cell Rep 2017;3:35-44. [PMID: 28261549 DOI: 10.1007/s40778-017-0075-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
76 Ferrini A, Stevens MM, Sattler S, Rosenthal N. Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation. Front Cardiovasc Med 2019;6:26. [PMID: 30949485 DOI: 10.3389/fcvm.2019.00026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
77 Fernández-Colino A, Iop L, Ventura Ferreira MS, Mela P. Fibrosis in tissue engineering and regenerative medicine: treat or trigger? Adv Drug Deliv Rev 2019;146:17-36. [PMID: 31295523 DOI: 10.1016/j.addr.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
78 Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
79 Afari ME, Syed W, Tsao L. Implantable devices for heart failure monitoring and therapy. Heart Fail Rev 2018;23:935-44. [PMID: 29524066 DOI: 10.1007/s10741-018-9687-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
80 Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG. ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovasc Res 2019;115:488-500. [PMID: 30657875 DOI: 10.1093/cvr/cvz010] [Cited by in F6Publishing: 43] [Reference Citation Analysis]